PET Track (10 CME credits)

ASNC2017: PET Track On Demand

Overall Description

This On Demand activity is comprised of sessions and presentations from the PET Track of the live ASNC2017 22nd Annual Scientific Meeting September 14-17, 2017 in Kansas City, MO. The focus is to showcase current best practices when performing nuclear cardiology imaging studies using Positron Emission Tomography (PET).

Activity Release Date: 10/27/2017
Activity Expiration Date: 10/26/2018
Activity Last Review Date: September 30, 2017

Estimated time to complete this activity is 10 hrs.

Statement of Need

In order to maintain competence and improve performance for best patient outcomes, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced.

Overall Purpose:
The overall goal of this activity is to enhance physician knowledge, competence and skills in applications about appropriate use criteria, radiation safety, reporting, and lab performance in using appropriate guidelines-based treatment.

Learning Objectives:

  • Understand the clinical applications and interpretation of cardiac perfusion and flow assessment with PET
  • Learn how PET is helpful in the interpretation of CAD
  • Describe recent advances in nuclear cardiology using positron emission tomography (PET)
  • Understand the advantages of PET and the role of quantification of myocardial blood
  • Evaluate the strengths and weaknesses of patient-centered imaging procedures and how they can be most effectively incorporated into clinical practice using PET

Target Audience

This online activity is intended for cardiologists, radiologists, nuclear medicine specialists, and other health care professionals involved in the field of nuclear cardiology.

Accreditation and Continuing Education Credit

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for a maximum of 10 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASNC has achieved Accreditation with Commendation


Organizing Committee

Prem Soman, MD, PhD, FASNC, Chair
Brian G. Abbott, MD, MASNC
Firas Al Badarin, MD, FASNC
Karthikeyan Ananthasubramaniam, MD, FASNC



Timothy L. Dunn, CNMT
Raymond R. Russell, MD, PhD, FASNC
Randall C. Thompson, MD, FASNC


Program Committee

Donna M. Polk, MD, MPH, FASNC, Chair
Sharmila Dorbala, MD, FASNC, Vice Chair
James A. Arrighi, MD, MASNC
Dennis Calnon, MD, FASNC
Panithaya Chareonthaitawee, MD
Marcelo Di Carli, MD
Jane Dunne (ASNC staff)
Andrew J. Einstein, MD, PhD, FASNC
Oliver Gaemperli, MD
Fadi Hage, MD, FASNC
Christopher L. Hansen, MD, FASNC
Matthew E. Harinstein, MD
Gary V. Heller, MD, PhD, MASNC
Edward Hulten, MD, MPH, FASNC
Juhani Knuuti, MD, PhD
April Mann, MBA, CNMT, RT(N), NCT, FASNC
Edward J. Miller, MD, PhD, FASNC


Rob S.B. Beanlands, MD, FASNC
Jamieson M. Bourque, MD, FASNC
Renee Bullock-Palmer, MD, FASNC
Todd D. Miller, MD
Khurram Nasir, MD, MPH
Robert A. Pagnanelli, CNMT, RT(N)(R), FASNC
Mi-Ae Park, PhD
Matthew Parker, MD
Lawrence M. Phillips, MD, FASNC
Raymond R. Russell, III, MD, PhD, FASNC
Ibrahim M. Saeed, MD
Maria G. Sciammarella, MD
Nishant R. Shah, MD, MPH
Albert J. Sinusas, MD, FASNC
Mark I. Travin, MD, FASNC
James E. Udelson, MD, MASNC



As an Accreditation Council for Continuing Medical Education (ACCME) accredited continuing medical education (CME) provider, ASNC must insure balance, independence, objectivity, and scientific rigor in all of its continuing medical education activities. In order to achieve these goals, we require everyone who is in a position to control the content of an educational activity to disclose to us all relevant financial relationships with any commercial interest. These relationships are those in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected. We also consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. With respect to personal financial relationships, ‘contracted research’ includes research funding where the institution receives the grant and manages the funds and the person is the principal or named investigator on the grant. Relevant financial relationships are financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. In addition, should it be determined that a conflict of interest exists as a result of a financial relationship a planner or a speaker may have, it will be resolved prior to the activity. ASNC also requires that all faculty presenters disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations.

1 designates presenter
2 designates peer reviewer/moderator
3 designates planner

The following individuals have stated that they have no relevant financial relationships with any commercial interest that produces health care goods or services, including computer software/hardware, related to the content of the educational presentation in which they are involved:

1,2Abbott, Brian
1,2,3Ananthasubramaniam, Karthik
1,2,3Arrighi, James
1,3Arumugam, Parthiban
1Birnie, David
1,2,3Bourque, Jamieson
1,2,3Bullock-Palmer, Renee
1,2,3Chareonthaitawee, Panithaya
1Chih, Sharon

1Cooper, Leslie
1,3Cremer, Paul
1Dhar, Ritesh
1,2,3Dunn, Timothy
2Dunne, Jane
1,3Iskandrian, Ami
2Gaemperli, Oliver
1,2Harinstein, Matthew
1,2,3Heller, Gary
1,3Holly, Thomas
1,2Hulten, Edward

2Knuuti, Juhani
1,3Miller, Todd
2Nasir, Khurram
1,2Park, Mi-Ae
1,2,3Phillips, Lawrence
1,2,3Polk, Donna
1,3Ruddy, Terrence
1,2,3Saeed, Ibrahim
1,3Sciammarella, Maria
1,2Sinusas, Albert
1,3Schockling, Eric

1,3Skali, Hicham
1,3Taqueti, Viviany 1,2,3Thompson, Randall
1,2,3Travin, Mark
1,3Verberne, Hein





Relevant financial relationships with commercial interests have been stated as noted by the following planners, presenters and moderators:

2Al Badarin, Firas
Speakers Bureau: Lantheus

2Beanlands, Rob
Consulting Fee: Lantheus Medical Imaging Jubilant DRAXImage
Research Grant or Contractor: Lantheus Medical Imaging Jubilant DRAXImage, GE Healthcare

1Al-Mallah, Mouaz
Consulting Fee: Pfizer
Honoraria: Pfizer, Novartis

1,3Bateman, Timothy
Intellectual Property Rights: CVIT
Honoraria: Bracco
Research Grant or Contractor: Astellas GE
Advisory Board: AIM
Royalty: CVIT
Stock Interest: CVIT

1,3Blankstein, Ron
Consulting Fee: EKOS Corp., Stealth Peptides
Research Grant or Contractor: Amgen, Gilead
Advisory Board: Amgen

1,2,3Calnon, Dennis
Consulting Fee: Navidea Biopharmaceuticals
Research Grant or Contractor:

1Case, James
Intellectual Property Rights: CVIT
Research Grant or Contractor: Astellas, General Electric
Stock Interest: CVIT
Salaried Employee: CVIT

1deKemp, Robert
Intellectual Property Rights: Ottawa Heart Inst.
Consulting Fee: Jubilant Draximage
Research Grant or Contractor: Jubilant Draximage
Royalty: Ottawa Heart Inst.

1,2Di Carli, Marcelo
Research Grant or Contractor: Spectrum Dynamics
Advisory Board: Sanofi

1,2,3Dorbala, Sharmila
Research Grant or Contractor: Astellas
Stock Interest: General Electric

1,2,3Einstein, Andrew
Consulting Fee: GE Healthcare
Research Grant or Contractor: Philips, Toshiba

1,3Gropler, Robert
Consulting Fee: Sanofi
Research Grant or Contractor: Bayer, NIH, Biomedical

1,2Hage, Fadi
Research Grant or Contractor: Astellas, Novartis

1,2,3Hansen, Christopher
Consulting Fee: Digirad
Royalty: General Electric

1,3Hyafil, Fabien
Consulting Fee: Naogen
Honoraria: Curium

1Maddahi, Jamshid
Consulting Fee: Lantheus Medical Imaging, Astellas
Research Grant or Contractor: Lantheus Medical Imaging
Speakers Bureau: Astellas

2Mann, April

Advisory Board: Astellas Pharma USA

1,2,3Miller, Edward
Consulting Fee: GE, Inc
Research Grant or Contractor: Bracco, Inc

1,2,3Pagnanelli, Robert
Speakers Bureau: Astellass

1,3Parker, Matthew
Consulting Fee: Intersocietal Accreditation Commission-PET/Nuclear peer review

1,2,3Russell, Raymond
Stock Interest: Novartis (spouse)
Salaried Employee: Novartis (spouse)

1,3Shah, Nishant
Stock Interest: General Electric

1,3Schindler, Thomas
Research Grant or Contractor: Research grant from Siemens Medical Solutions to evaluate the image quality of cardiac perfusion studies with the novel Intevo -SPECT/CT.

1,2,3Soman, Prem
Research Grant or Contractor: Astellas
Advisory Board: Alnylam Pharma

1,2,3Udelson, James
Advisory Board: Lantheus








The information in this activity represents the opinion of the faculty and is not necessarily the official position of ASNC.

Policy on Off Label Use

Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

Method of Participation and CME Certificates
To receive CME credit for this product, you must:

  1. Purchase the product.
  2. Read the CME front matter.
  3. View the session(s) of your choosing.
  4. Click the CE Information tab on individual sessions, and the Test button.
  5. Complete the post-test. Your must score 75% to earn credit. You may take the test as many times as you need to score 75%.
  6. When you are finished watching the session of your choosing, your certificate will reflect the total accumulated credits from the session. Generate and print your CME certificate.
  7. If you would like a transcript, or a breakdown of all credits claimed across all the ASNC2017 content, visit the My Account area and click on the tab on the left labeled Certificates and Transcripts. As you take more sessions, this transcript will automatically update with the additional credtis.

Medium or Combination of Medium Used:
This is an on demand activity with slides synchronized with audio.

Commercial Acknowledgement
This activity has not received commercial support

Hardware/Software Requirements
For the most current list of system requirements, please visit

For technical support please contact: or (716)338-0332 ; Toll Free (877)796-1325 (U.S.A. only)

ASNC Contact Information:

American Society of Nuclear Cardiology
4340 East-West Highway, Suite 1120
Bethesda, MD 20814-4578
Phone: (301) 215-7575
Fax: (301) 215-7113

Privacy Policy

This website is provided by Digitell Inc. We do not share information about individuals with anyone other than the credit card processors and the shipping company.

The complete Privacy Policy can be found by clicking Privacy Policy at the bottom of

Standard: $350.00
Members: $250.00